186 related articles for article (PubMed ID: 12468339)
1. Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significance.
Stackievicz R; Drucker L; Zemer R; Klein A; Markovitch O; Yarkoni S
Gynecol Oncol; 2002 Oct; 87(1):34-8. PubMed ID: 12468339
[TBL] [Abstract][Full Text] [Related]
2. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
6. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
8. Gestational Trophoblastic Disease: Contemporary Diagnostic Approach.
Buza N
Surg Pathol Clin; 2022 Jun; 15(2):197-218. PubMed ID: 35715158
[TBL] [Abstract][Full Text] [Related]
9. [The expression of EMT associated protein CK-18 and vimentin in gestational trophoblastic disease ].
Cai Y; Xue Y; An RF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):960-3, 1014. PubMed ID: 25571724
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Early Transformation of Gestational Trophoblastic Neoplasia Following Molar Pregnancy.
Erfiandi F; Mantilidewi KI; Hidayat YM; Harsono AB; Suardi D; Salima S; Kurniadi A; Islami IP; Agustina H; Dewayani BM; Nisa AS; Toriq H
Am J Case Rep; 2021 May; 22():e930789. PubMed ID: 33972495
[TBL] [Abstract][Full Text] [Related]
11. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.
Strickland AL; Gwin K
Semin Diagn Pathol; 2022 May; 39(3):228-237. PubMed ID: 35400536
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of laminin receptor 1 on decidual cells in partial and complete mole.
Nagymanyoki Z; Callahan MJ; Parast MM; Berkowitz RS; Mok SC; Fulop V
Gynecol Oncol; 2008 Jan; 108(1):121-5. PubMed ID: 17928039
[TBL] [Abstract][Full Text] [Related]
14. Pathology of gestational trophoblastic diseases.
Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
[TBL] [Abstract][Full Text] [Related]
15. Can Ki67 and Caspase Predict Molar Progression?
Nagib RM; M A Zaki M; Wageh A; Abdelrazik M
Fetal Pediatr Pathol; 2019 Oct; 38(5):444-448. PubMed ID: 31038005
[No Abstract] [Full Text] [Related]
16. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
17. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
18. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
19. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance.
Wang Y; Cao Y; Sun Y
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):123-5. PubMed ID: 12658752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
